MTOR and cervical cancer: Additionally, mTOR agonist had no effect on the proliferation of cervical cancer cells in the presence of isoflurane and HDAC6 siRNA, indicating that isoflurane-induced proliferation of cells is mediated by mTOR-dependent HDAC6 pathway.